Cognitive Conditioned Pain Modulation

NCT ID: NCT07234123

Last Updated: 2026-01-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

24 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-08-09

Study Completion Date

2025-05-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This "pain reduces pain" study looks at how the brain reduces pain when a person feels two painful sensations at the same time. There is considerable evidence that the brain can "turn down" pain using natural endogenous pain-control systems. The current CPM study measures whether attentional processes can also make a measurable contribution to pain inhibition alongside neurochemical mechanisms.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditioned pain modulation (CPM) is a natural process where feeling pain in one part of the body (e.g., a conditioning stimulus to the wrist) can reduce pain felt in another part of the body (a test stimulus to the foot). There is considerable evidence from both animal and human studies that the painful conditioning stimulus can stimulate the brain to activate neurochemical pain-control pathways (e.g., endogenous opioids), which are believed to take 30-120 seconds to fully engage. The current CPM study measures whether attentional processes can also make a measurable contribution to pain inhibition alongside neurochemical mechanisms.

Primary measures: Graphic ratings scale "worst pain" ratings.

The primary measure of the current study graphic ratings scales (worst pain ratings) will measure how much pain participants feel on their foot during foot only (test stimulus), vs. how much pain participants feel on their foot (test stimulus during simultaneous foot (test stimulus) + wrist (conditioning stimulus).

The current investigators predict that pain (e.g., the conditioning stimulus) naturally demands attention and can pull attention away from the original pain source (the test stimulus), resulting in CPM-like reductions in pain of the test stimulus.

Secondary measure #1. Cognitive measures are introduced in the current study, to quantify how much (if at all) the conditioning stimulus reduces pain of the target stimulus via attentional mechanisms. Participants estimate what percentage of their attention was directed to their foot (the test stimulus) during foot only vs. during foot + wrist (test + conditioning stimulus). This will measure whether the conditiioning stimulus to the wrist reduces how much attention participants focus on their foot. Analyses will also measure whether the amount of attention shift away from the foot (via participants; subjective ratings) is correlated with CPM robustness (reduction in pain of foot during duel stimulation).

Secondary measure #2. As another secondary measure of attention during one vs. two simultaneous pain stimuli, this study involves a divided attention auditory listening task that becomes harder when pain demands more attention (Craik et al., odd number divided attention task during single test pain stimuli vs. simultaneous test + conditioning stimuli). The more errors the participant makes on the divided attention task, the more attention diverted away from the auditory task by pain. Analyses will measure whether the number of errors on the divided attention task is correlated with CPM robustness (reduction in pain of foot, during duel thermal stimulation).

Exploratory measures. As exploratory measures, participants will rate how distracted they were and how difficult it was to concentrate (on 0-10 rating scales during test stimulus alone verses test + conditioning noxious thermal heat stimuli).

In summary, embedding these cognitive measures into the CPM protocol may enhance mechanistic interpretation accuracy by quantifying attentional contributions to pain inhibition in specific CPM protocols, thereby complementing existing approaches to pain phenotyping and reducing unexplained variance in CPM outcomes.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Participants

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

CROSSOVER

within-subject design
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Single pain stimulus

test pain stimulus alone

Group Type EXPERIMENTAL

test stimulus

Intervention Type BEHAVIORAL

single brief stimulus to foot only

dual pain stimuli

simultaneous foot (test stimulus + wrist (conditioning stimulus)

Group Type EXPERIMENTAL

conditioned pain modulation

Intervention Type BEHAVIORAL

simultaneous stimuli to foot (test stimulus) and wrist (conditioning stimulus)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

conditioned pain modulation

simultaneous stimuli to foot (test stimulus) and wrist (conditioning stimulus)

Intervention Type BEHAVIORAL

test stimulus

single brief stimulus to foot only

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Only University of Washington students in eligible psychological courses are
* eligible. General public is not eligible.
* Enrolled psychology students fluent in English,
* Age ≥18 y, able to follow instructions.

Exclusion Criteria

* Seizure history,
* Migraines,
* Diabetes,
* Extreme pain insensitivity,
* Motion sickness,
* or prior participation in this protocol.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Mayday Fund

OTHER

Sponsor Role collaborator

University of Washington

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Hunter Hoffman

Research Scientist

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Hunter Hoffman

Role: PRINCIPAL_INVESTIGATOR

University of Washington

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Washington Seattle

Seattle, Washington, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Yarnitsky D. Conditioned pain modulation (the diffuse noxious inhibitory control-like effect): its relevance for acute and chronic pain states. Curr Opin Anaesthesiol. 2010 Oct;23(5):611-5. doi: 10.1097/ACO.0b013e32833c348b.

Reference Type BACKGROUND
PMID: 20543676 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CPM2025

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

3h of PNE on BDNF and Pain Levels
NCT05736172 RECRUITING NA
Pain Modulation Effectiveness (PME)
NCT05783362 COMPLETED NA